Clorox (CLX) Q3 2026 earnings review
Sales Stabilize, But Gross Margin Outlook Collapses
Clorox finally halted its ERP-induced revenue slide, posting flat sales in Q3. However, the top-line stabilization masks severe profitability issues. Management brutally slashed full-year gross margin and earnings guidance, citing new Middle East energy costs, higher manufacturing expenses, and integration friction from the newly acquired GOJO (Purell) business. While Adjusted EPS of $1.64 beat the prior-year quarter, the forward-looking narrative is flashing red. The cost of running this business is rising faster than pricing power can offset.
🐂 Bull Case
After a disastrous Q1 (-19% sales) driven by ERP implementation failures, top-line volumes are stabilizing. Q3 organic volumes were down just 1%, a vast improvement from the massive out-of-stocks seen earlier in the year.
The GOJO Industries acquisition closed on April 1, bringing the powerhouse Purell brand into the Health and Wellness segment. This will immediately add ~3 points to top-line sales growth.
🐻 Bear Case
Management originally guided FY26 gross margins down 50-100 bps. They have now slashed that to a decline of 250-300 bps. Higher energy costs, logistics, and GOJO inventory step-ups are crushing profitability.
The Lifestyle segment (Food, Water Filtration, Personal Care) remains a severe laggard. Sales dropped 9% in Q3, driven almost entirely by a 6% collapse in volume due to weak consumption.
⚖️ Verdict: 🔴
Bearish. Breaking the streak of revenue declines is a positive step, but cutting the full-year EPS guidance by roughly 10% this late in the fiscal year shows management has lost its grip on the cost structure.
Key Themes
The Gross Margin Collapse
The most alarming data point in this report is the slashed margin guidance. Gross margin fell 140 bps in Q3 to 43.2%. Worse, full-year guidance was downgraded from a 50-100 bps decline to a 250-300 bps decline. Management explicitly blamed a combination of higher Middle East energy costs, unfavorable product mix, and 60 bps of headwinds from the GOJO acquisition (primarily transaction and inventory step-up costs).
Lifestyle Segment Continues to Bleed
If Clorox has an anchor weighing it down, it is the Lifestyle segment. Net sales fell 9% YoY, driven by a 6% drop in volume. This segment has consistently underperformed the company average. Management attributes this to lower consumption and retail inventory adjustments. Until consumers return to discretionary food and water filtration products, this segment remains a glaring concern.
The GOJO Era Begins, Bringing Near-Term Pain
Clorox officially integrated GOJO (Purell) on April 1. While this is an excellent long-term strategic fit that will add 3% to FY26 sales, it brings immediate financial friction. The deal is diluting FY26 Adjusted EPS by 2 to 4 cents, primarily due to financing interest and inventory fair-value step-ups. It is EBITDA margin neutral, but has a fundamentally different gross margin profile that is lowering the total company average.
Glad JV Buyout Clears Future Margin Hurdles
Clorox executed a $476 million termination payment to buy out P&G's 20% interest in the Glad joint venture. While this artificially crushed Q3 operating cash flow (-59% YoY), it fundamentally shifts the economics of the Trash business. By eliminating the royalty payment to P&G, Clorox has secured a permanent structural tailwind to its gross margins moving forward.
The ERP Hangover Dictates FY26 Comparisons
The massive retailer inventory pre-build ahead of the ERP transition in late FY25 continues to warp the financials. The subsequent inventory drawdown is masking true consumer demand. Management expects this dynamic to strip a massive 7.5 percentage points from FY26 net sales growth and drag down earnings by roughly $0.90 per share. True underlying demand won't be clean to analyze until FY27.
Targeted Innovation Holding the Line
Despite macro consumer pressures, Clorox is forcing growth in specific pockets via continuous innovation. Management highlighted velocities exceeding expectations for the new Clorox PURE line. They are also leaning heavily into premiumization and line extensions, specifically calling out Hidden Valley Ranch with Avocado Oil and new Burt's Bees lip treat platforms. These premium offerings are critical to fighting the negative price/mix headwinds.
Other KPIs
Reversing. Plunged 59% from $687 million in the year-ago period. However, this is heavily distorted by the $476 million one-time Glad joint venture termination payment to P&G. When adjusted for this payment and capital expenditures, non-GAAP Free Cash Flow actually improved to $637 million (13.3% of sales), indicating healthy underlying cash conversion despite the P&L noise.
Accelerating. Up 21% YoY on a 3% sales increase. This was the only segment to show meaningful profitability improvement in Q3, driven almost entirely by cost savings and timing of shipments ahead of consumption in Cat Litter and Grilling categories.
Guidance
Stable compared to prior guidance, but highly nuanced. Organic sales are now expected to decrease ~9% (decelerating from the prior -5% to -9% outlook). The only reason total net sales guidance didn't completely collapse is the ~3% artificial boost provided by the GOJO acquisition.
Decelerating. Cut severely from the previous range of $5.95 - $6.30. This represents a 27% to 29% YoY decrease. The revision embeds a 2-4 cent dilution from the GOJO acquisition, but the vast majority of the downgrade stems from collapsing gross margins and the sustained $0.90 penalty from the ERP shipment reversal.
Decelerating violently. Previously guided down 50 - 100 bps. The ~200 bps sequential downgrade is driven by Middle East energy cost inflation, higher manufacturing/logistics expenses, and 60 bps of headwinds from GOJO transaction costs and inventory step-ups.
Key Questions
Energy Costs vs Structural Inflation
You cited Middle East energy costs as a driver for the massive gross margin guidance cut. How much of this 200 bps downgrade is tied to volatile commodity pricing versus sticky, structural manufacturing and logistics inefficiencies?
GOJO Path to Accretion
GOJO brings immediate EPS dilution and gross margin headwinds. Once the inventory step-ups roll off, what is the specific timeline and margin profile expectation for this business to become accretive to total company gross margins?
Lifestyle Segment Interventions
The Lifestyle segment continues to shed volume (-6% this quarter). Aside from reducing advertising to protect segment EBIT, what aggressive commercial actions are planned to halt the volume bleed in Food and Water Filtration?